A 4-weekly course of rituximab is safe and improves tumor control for patients with minimal residual disease persisting 3 months after autologous hematopoietic stem-cell transplantation: results of a prospective multicenter phase II study in patient
| Image |  |
|---|---|
| Description | scientific article published on 05 July 2012 |
| Author/s |
author: Remy Gressin Corinne Haioun Noel Jean Milpied Gilles Salles |
| Publication date | July 5, 2012 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |